Disrupt CAD III
ClinicalTrials.gov NCT03595176
Research payments
$396,617
Through program year 2022, $396,617 in research payments was reported against Disrupt CAD III, across 186 payments, paid by Shockwave Medical, Inc.
- Paid by
- Shockwave Medical, Inc
- ClinicalTrials.gov
- NCT03595176
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $396,617 | 186 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Richard Shlofmitz Port Washington, NY Named on 11 payments
- Matthew Price San Diego, CA Named on 10 payments
- Mohamed Azeem Latib New York, NY Named on 9 payments
- Robert Stoler Dallas, TX Named on 8 payments
- John Wang Baltimore, MD Named on 7 payments
- Atul Sharma New York, NY Named on 7 payments
- Andrew Klein Atlanta, GA Named on 7 payments
- Ron Waksman Washington, DC Named on 7 payments
- Rony Lahoud South Burlington, VT Named on 7 payments
- Keith Benzuly Chicago, IL Named on 7 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.